A new study shows that people are likely to continue taking GLP-1 drugs like Ozempic, which is commonly prescribed off-label ...

Higher protein intake may improve short-term hip bone strength during weight loss in older adults with overweight or obesity ...

Experts break down why working out isn’t the best way to burn calories.

Scientists have discovered a brain signaling pathway that eliminates body fat without reducing food intake by targeting ...

Patients who use semaglutide for weight loss, like Ozempic, are more likely to continue the medication if they perceive it as ...

Eli Lilly plans to make India a global supply chain hub, expanding Mounjaro production and launching new drugs amid rising ...

Having different chronotypes, or being more active in the morning vs. afternoon, may play an important role in preserving muscle mass and strength, and metabolic health, according to a new study.

Eli Lilly’s plant is set to inject 850 high-paying jobs into Pennsylvania's Lehigh Valley, potentially triggering home price ...

The mechanism remains unclear, but GLP-1 users had less MACE, CV death, and all-cause death driven by fewer amputations.

Eli Lilly had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug ahead of an expected decision by the U.S. Food and Drug Administration in April, Reuters writes, ...

A new study found that a combination of hormone therapy and the GLP-1 medication tirzepatide (Zepbound) led to 35% more ...

About 20 years ago, the U.S. Food and Drug Administration approved the first GLP-1 medication for Type 2 diabetes. Today, the landscape has shifted, as the agency has approved various ...